Verus Capital Partners, LLC Bio Techne Corp Transaction History

Verus Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$322.67 - $449.65 $179,404 - $250,005	-556 Closed	0 $0
Q1 2022 Aug 09, 2022	SELL	$353.85 - $487.79 $174,801 - $240,968	-494 Reduced 47.05%	556 $207,000
Q1 2020 May 26, 2020	SELL	$161.17 - $221.51 $8,058 - $11,075	-50 Reduced 4.55%	1,050 $199,000
Q4 2019 Feb 27, 2020	BUY	$189.68 - $222.09 $208,648 - $244,299	1,100 New	1,100 $241,000

605

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Verus Capital Partners, LLC with notifications on news.